NervGen Pharma Corp. (NGEN)
2.32
+0.11
(+4.98%)
USD |
NASDAQ |
Sep 01, 16:00
2.33
+0.01
(+0.43%)
After-Hours: 17:37
NervGen Pharma Cash from Investing (Quarterly) : -0.0001M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0001M |
| March 31, 2026 | 0.0061M |
| December 31, 2025 | 0.0174M |
| September 30, 2025 | 0.0185M |
| June 30, 2025 | 0.0189M |
| March 31, 2025 | 0.0176M |
| December 31, 2024 | 0.0174M |
| September 30, 2024 | 0.0185M |
| June 30, 2024 | 0.0061M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0016M |
| September 30, 2023 | -0.1033M |
| June 30, 2023 | -0.0022M |
| March 31, 2023 | 0.0019M |
| December 31, 2022 | 0.0006M |
| September 30, 2022 | -0.0041M |
| June 30, 2022 | -0.0078M |
| March 31, 2022 | -0.0043M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0013M |
| June 30, 2021 | -0.0345M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0001M |
| September 30, 2020 | -0.0001M |
| June 30, 2020 | 0.0001M |
| March 31, 2020 | -0.0025M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0091M |
| September 30, 2018 | -0.0869M |
| June 30, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 0.00 |
| Milestone Pharmaceuticals, Inc. | 111.84M |
| Clearmind Medicine, Inc. | -0.6541M |
| Lexaria Bioscience Corp. | -0.0271M |
| Target Group, Inc. (Canada) | -0.0065M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.086M |
| Cash from Financing (Quarterly) | 56.43M |
| Free Cash Flow | -18.43M |
| Free Cash Flow Per Share (Quarterly) | -0.0442 |
| Free Cash Flow to Equity (Quarterly) | -4.086M |
| Free Cash Flow to Firm (Quarterly) | -4.086M |
| Free Cash Flow Yield | -9.85% |